As of 2025-12-31, the EV/EBITDA ratio of Sutro Biopharma Inc (STRO) is -0.07. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. STRO's latest enterprise value is 11.34 mil USD. STRO's TTM EBITDA according to its financial statements is -166.33 mil USD. Dividing these 2 quantities gives us the above STRO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.8x - 15.4x | 15.4x |
| Forward P/E multiples | 20.7x - 26.9x | 22.3x |
| Fair Price | (510.05) - (377.41) | (462.95) |
| Upside | -4470.6% - -3334.0% | -4067.0% |
| Date | EV/EBITDA |
| 2025-12-26 | -0.06 |
| 2025-12-24 | -0.03 |
| 2025-12-23 | -0.02 |
| 2025-12-22 | -0.02 |
| 2025-12-19 | -0.00 |
| 2025-12-18 | 0.04 |
| 2025-12-17 | 0.03 |
| 2025-12-16 | 0.01 |
| 2025-12-15 | 0.00 |
| 2025-12-12 | 0.01 |
| 2025-12-11 | 0.01 |
| 2025-12-10 | 0.04 |
| 2025-12-09 | 0.06 |
| 2025-12-08 | 0.06 |
| 2025-12-05 | 0.05 |
| 2025-12-04 | 0.02 |
| 2025-12-03 | 0.05 |
| 2025-12-02 | 0.11 |
| 2025-12-01 | 0.08 |
| 2025-11-28 | 0.03 |
| 2025-11-26 | 0.04 |
| 2025-11-25 | 0.05 |
| 2025-11-24 | 0.05 |
| 2025-11-21 | 0.06 |
| 2025-11-20 | 0.06 |
| 2025-11-19 | 0.03 |
| 2025-11-18 | 0.04 |
| 2025-11-17 | 0.06 |
| 2025-11-14 | 0.04 |
| 2025-11-13 | 0.03 |
| 2025-11-12 | 0.07 |
| 2025-11-11 | 0.07 |
| 2025-11-10 | 0.08 |
| 2025-11-07 | 0.07 |
| 2025-11-06 | 0.02 |
| 2025-11-05 | 0.00 |
| 2025-11-04 | -0.01 |
| 2025-11-03 | -0.04 |
| 2025-10-31 | -0.05 |
| 2025-10-30 | -0.07 |
| 2025-10-29 | -0.02 |
| 2025-10-28 | -0.04 |
| 2025-10-27 | -0.07 |
| 2025-10-24 | -0.02 |
| 2025-10-23 | -0.03 |
| 2025-10-22 | -0.07 |
| 2025-10-21 | -0.08 |
| 2025-10-20 | -0.06 |
| 2025-10-17 | -0.01 |
| 2025-10-16 | 0.05 |